Trials / Completed
CompletedNCT06446024
Post Market Surveillance to Evaluate the Efficacy and Safety of the INDIGO Aspiration System in Japan
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (actual)
- Sponsor
- Penumbra Inc. · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This study aims to confirm the safety and effectiveness of the INDIGO Aspiration System in patients requiring immediate treatment for acute lower extremity artery occlusion, acute superior mesenteric artery occlusion, or severe acute deep vein thrombosis. Primary objective of the study is to collect predetermined data on use, safety and effectiveness, including clinical and technical performance of the INDIGO System in Japan.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Mechanical aspiration thrombectomy | Mechanical thrombectomy is an endovascular technique for removing blood clots from vessels. Penumbra's Indigo system actively extracts thrombus using a continuous vacuum pump, enabling aspiration of thrombus of various sizes and lengths. |
Timeline
- Start date
- 2023-12-07
- Primary completion
- 2025-07-25
- Completion
- 2025-07-25
- First posted
- 2024-06-06
- Last updated
- 2026-02-04
Locations
1 site across 1 country: Japan
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT06446024. Inclusion in this directory is not an endorsement.